Dr Henrik Jungaberle covers the INSIGHT 2023 themes, and the importance of scientific rigour in the expanding field of psychedelic therapy.
Research is evaluating risks and suitability of MDMA assisted therapy for 15-17 year olds with PTSD. Ethically rigorous studies are needed to evaluate safety and efficacy.
The two pilot studies, one on depression in Alzheimer's and one on Lyme disease, assess if psilocybin offers alternatives to ineffective standard treatments.
Five new guidelines were presented in the ESC Congress: acute coronary syndromes; heart failure; cardiomyopathies; cardio-vascular disease and diabetes; and endocarditis.
Where does Italy stand in psychedelic drug research? We discuss this with Dr Matteo Buonarroti, the first Italian doctor to complete the Mind Foundation's Augmented Psychotherapy Training.
Cardiovascular events are the number one cause of death. Guidelines for all acute coronary syndromes have been published just in time for the 2023 ESC Congress.
The experiment, sent to the ISS, looks into the molecular mechanism behind an innovative pharmaceutical protocol to combat prion diseases.
Drowning deaths are a serious public health problem worldwide. Drowning victims require rapid and skilled intervention.
Severe congenital neutropenia increases the risk of myelodysplastic syndrome and acute myeloid leukaemia. What do we know today about the haematological processes that lead to leukaemogenesis?
No drug tackled the cause of ATTR-CM - the deposition of misfolded transthyretin in the heart muscle tissue. Until a phase I study tested a new recombinant antibody.
A meta-analysis examined the timing of postoperative thromboembolic events. What are the implications of this research for treatments?
More data suggests a link between exposure to environmental toxins such as pesticides and heavy metals, and the rise of Parkinson's disease.
Recent studies show the benefit of renal denervation in severe or refractory hypertension. The ESH has started recommending it for some patients.
Ending long-term therapy of HBeAg-negative hepatitis B with NUC was believed to induce a functional cure. Data on this was very limited, until a new study.
A short history of a silent serial killer that we thought we'd got rid of in the 19th century, thanks to the Royal Navy, and a fair amount of empirical observations.
Dermatology may experience wide new tech applications, even more than other specialties. Although still in their early stages, 3D innovations are promising.
Smoke from forest fires is more toxic than "normal" air pollution, can remain in the air for a long time and travel very long distances.
The microbiome is crucial for immunity, metabolic homeostasis, and protection from pathogens. What about its role in haematological diseases?
Two recent studies look at the efficacy of mirikizumab and upadacitinib in ulcerative colitis and Crohn's disease. Can IBD patients benefit?
There is a recent controversy about the influence and use of social media among children and young people. What are the biggest dangers and opportunities?